➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKesson
Johnson and Johnson
Baxter
Boehringer Ingelheim

Last Updated: July 8, 2020

DrugPatentWatch Database Preview

OXYCODONE HYDROCHLORIDE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Oxycodone Hydrochloride, and when can generic versions of Oxycodone Hydrochloride launch?

Oxycodone Hydrochloride is a drug marketed by Ani Pharms Inc, Avanthi Inc, Genus Lifesciences, Lannett Co Inc, Mayne Pharma Inc, Novel Labs Inc, Abhai Llc, Alkem Labs Ltd, Ascent Pharms Inc, Aurolife Pharma Llc, Eywa, Hi Tech, Hikma, Pharm Assoc, Rhodes Pharms, Specgx Llc, Vistapharm, Wockhardt Bio Ag, Actavis Elizabeth, Alvogen, Amneal Pharms, Epic Pharma Llc, Nesher Pharms, Nuvo Pharm, Sun Pharm Inds Inc, Vintage Pharms, Barr Labs Inc, and Watson Labs. and is included in fifty NDAs.

The generic ingredient in OXYCODONE HYDROCHLORIDE is ibuprofen; oxycodone hydrochloride. There are sixty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ibuprofen; oxycodone hydrochloride profile page.

Drug patent expirations by year for OXYCODONE HYDROCHLORIDE
Recent Clinical Trials for OXYCODONE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
State University of New York at BuffaloPhase 3
Columbia UniversityPhase 4
Our Lady of the Lake HospitalN/A

See all OXYCODONE HYDROCHLORIDE clinical trials

Pharmacology for OXYCODONE HYDROCHLORIDE
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

US Patents and Regulatory Information for OXYCODONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 077290-003 Dec 8, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Vintage Pharms OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 077712-005 Apr 13, 2015 DISCN No No   Start Trial   Start Trial   Start Trial
Alvogen OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 202116-003 Dec 30, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Specgx Llc OXYCODONE HYDROCHLORIDE oxycodone hydrochloride SOLUTION;ORAL 210758-002 Apr 30, 2018 AA RX No No   Start Trial   Start Trial   Start Trial
Rhodes Pharms OXYCODONE HYDROCHLORIDE oxycodone hydrochloride TABLET;ORAL 091490-002 Mar 9, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKesson
Johnson and Johnson
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.